Komori
inspec (6656) · InitiativeAdvanced

Issuance of 2018 Stock Options for Directors

First written in FY2019-Q2. 12 of 13 entries say "Advanced", first in FY2021-Q2. Latest entry: 2026-09-16.

13entries
9years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019-Q2AdvancedFY2021-Q2 – 2026-09-162018: 12019: 020192020: 120202021: 120212022: 220222023: 120232024: 020242025: 120252026: 62026
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 658 companies write about · 0 as a headwind · 739 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 741 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「The stock acquisition rights issued under the Companies Act during the interim accounting period were as follows. <2025 Stock Acquisition Rights> Date of resolution: Board of Directors meeting, 8 August 2025; category and number of grantees: 4 company directors; number of stock acquisition rights*: 100; class, details and number of shares underlying the stock acquisition rights*: 10,000 common shares.」

    We granted 2025 stock acquisition rights to 4 directors and issued 100 rights covering 10,000 common shares. Under the 17th Series Stock Acquisition Rights, we also issued 200 rights covering 20,000 common shares to 7 directors, 3 audit & supervisory board members and 85 employees, indicating continued progress in granting equity incentives to officers and employees.
  2. FY2024-Q1AdvancedAnnual report

    「At a Board of Directors meeting held on 9 August 2023, pursuant to the authority granted by the annual general meeting held on 28 July 2023, we resolved to issue stock acquisition rights to our directors, audit & supervisory board members and employees, and issued them on 24 August 2023.」

    On 24 August 2023, we issued 200 stock acquisition rights covering 20,000 common shares to 6 directors, 3 audit & supervisory board members and 84 employees. The exercise period runs from 25 August 2025 to 8 August 2033.
  3. FY2023-Q2AdvancedAnnual report

    「<2022 Stock Acquisition Rights> Date of resolution Board of Directors meeting, 8 August 2022 Category and number of grantees 4 company directors Number of stock acquisition rights* 100 (Note 1) Class, details and number of shares underlying the stock acquisition rights* 10,000 common shares (Note 2) Exercise period* From 14 September 2022 To 13 September 2052 <15th Series Stock Acquisition Rights> Date of resolution Annual general meeting, 22 July 2022 Board of Directors meeting, 8 August 2022 Category and number of grantees 6 company directors, 3 company audit & supervisory board members, 71 company employees Number of stock acquisition rights* 200 (Note 1) Class, details and number of shares underlying the stock acquisition rights* 20,000 common shares Exercise period* From 24 August 2024 To 7 August 2032」

    We granted 2022 stock acquisition rights to 4 directors and the 15th Series Stock Acquisition Rights to 6 directors, 3 audit & supervisory board members and 71 employees. The grant recipients and administration of stock acquisition rights for officers and employees have progressed.
  4. FY2023-Q1AdvancedAnnual report

    「At a Board of Directors meeting held on 8 August 2022, pursuant to the authority granted by the annual general meeting held on 22 July 2022, we resolved to issue stock acquisition rights to our directors, audit & supervisory board members and employees, and issued them on 23 August 2022.」

    We issued 200 stock acquisition rights to 6 directors, 3 audit & supervisory board members and 71 employees, covering 20,000 common shares. The existing stock option programme for officers has progressed to a new grant stage.
  5. FY2022-Q2AdvancedAnnual report

    「The stock acquisition rights issued under the Companies Act during the second quarter of the current accounting period were as follows. <2021 Stock Acquisition Rights> Date of resolution: Board of Directors meeting, 12 August 2021; category and number of grantees: 4 company directors; number of stock acquisition rights*: 70; class, details and number of shares underlying the stock acquisition rights*: 7,000 common shares.」

    We granted 2021 stock acquisition rights to 4 directors and issued 70 rights covering 7,000 common shares. The exercise period runs from 15 September 2021 to 14 September 2051.
  6. FY2021-Q2AdvancedAnnual report

    「<2020 Stock Acquisition Rights> Date of resolution: Board of Directors meeting, 11 August 2020; category and number of grantees: 4 company directors; number of stock acquisition rights*: 100 (Note 1); class, details and number of shares underlying the stock acquisition rights*: 10,000 common shares (Note 2)」

    We issued 2020 stock acquisition rights to 4 directors, covering 10,000 common shares. The exercise period runs from 14 September 2020 to 13 September 2050.
  7. FY2019-Q2First statedAnnual report

    「The stock acquisition rights issued under the Companies Act during the second quarter of the current consolidated accounting period were as follows. <2018 Stock Options> Category and number of grantees: 3 company directors; number of stock acquisition rights: 100; class, details and number of shares underlying the stock acquisition rights: 10,000 common shares; exercise period: 20 September 2018 to 19 September 2048.」

    We issued 100 2018 stock options to 3 directors, covering 10,000 common shares. The exercise period runs from 20 September 2018 to 19 September 2048.
Moved together

"Strengthening product competitiveness centered on AOI and AVI" moved the same way as this thread, in the same document, in 5 of its 13 moves.

554432★123456
  1. ★This thread
  2. 1Strengthening product competitiveness centered on AOI and AVI5×
  3. 2Capital Raising through the Exercise of the Eighth Series of Stock Acquisition Rights5×
  4. 3Strengthening Global Sales Capabilities and Overseas Business Expansion4×
  5. 4Development and sales of roll-to-roll seamless laser direct-write exposure equipment for long-length FPCs4×
  6. 5Compensation Policy for Performance-Linked Compensation and Stock Compensation-Type Stock Options3×
  7. 6Dependence on Interest-Bearing Debt and Rising Interest Rates2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for inspec yet. It last moved in the Share Issuance and Disposal of 2026-09-16: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Issuance of 2018 Stock Options for Directors | inspec Inc. (6656) | Komori